Etanercept for the treatment of rheumatoid arthritis
32 results
1 - 32Etanercept for the treatment of rheumatoid arthritis
Etanercept for the treatment of rheumatoid arthritis: Cochrane systematic review
Rheumatoid arthritis
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Anakinra for rheumatoid arthritis
Anakinra for rheumatoid arthritis: Cochrane systematic review
Biologic interventions for fatigue in rheumatoid arthritis
Etanercept effective for plaque psoriasis in children
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis
Down‐titration and discontinuation strategies of TNF–blocking agents in rheumatoid arthritis
Combination therapy in rheumatoid arthritis
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis
Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics
Chronic diseases and pregnancy
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)
Adverse effects of biologics: a network meta‐analysis and Cochrane overview